Clinical trial · Interventional
Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts
Efficacy of Cryotherapy Combined With Intralesional Tuberculin Purified Protein Derivative (PPD) Versus Interlesional Tuberculin PPD Monotherapy in the Treatment of Multiple Common Warts
NCT04288817CI-TRIAL-00043698unknownPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigate the efficacy and safety of combined 'cryo-immuno-therapy' versus intralesional tuberculin purified protein derivative (PPD) antigen immunotherapy alone for multiple common warts
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Common Wart | Verruca Vulgaris | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Tuberculin purified protein derivative | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Cryotherapy and intralesional tuberculin PPD
- description
- Efficacy of cryotherapy combined with intralesional tuberculin purified protein in treatment of multiple common warts
- interventionNames
- Biological: Tuberculin purified protein derivative
- type
- ACTIVE_COMPARATOR
- label
- Intralesional tuberculin PPD
- description
- Efficacy of Intralesional tuberculin purified protein deravative monotherapy in the treatment of multiple common warts
- interventionNames
- Biological: Tuberculin purified protein derivative
Primary outcomes (2)
- measure
- Size of lesions
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: 1. A dults older than 18 years 2. multiple (\>3 warts) common warts . 3. not currently using other treatments for a wart . 4. not had relapsed at least once after treatment with any of the tissue-destructive modalities. 5. Positive tuberculin skin test. Exclusion Criteria: * Acute febrile illness, history of asthma, allergic skin disorders.-1 2- Pregnancy or lactation. 3- Cold-induced diseases. 4- Immunosuppression.
References
Publications (1)
- DERIVEDAwad SM, Gomaa AS, Hassan HA, Tawfik YM. Efficacy of Cryotherapy Combined With Intralesional Purified Protein Derivative (PPD) Versus Intralesional PPD Monotherapy in the Treatment of Multiple Common Warts. J Cutan Med Surg. 2023 Mar-Apr;27(2):117-125. doi: 10.1177/12034754231152224. Epub 2023 Jan 27. PMID 36705474